Haemonetics Corp (HAE)

75.44 -1.46 (-1.90%) USD  |  NYSE  |  Dec 20, 16:00
75.37 -0.07 (-0.09%) Pre-Market: 20:00
More

Haemonetics Debt to Equity Ratio: 1.394 for Sept. 30, 2024

Debt to Equity Ratio Chart

View Debt to Equity Ratio for HAE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Debt to Equity Ratio Definition

View Debt to Equity Ratio Definition
Start Trial

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Boston Scientific Corp 0.5254
ResMed Inc 0.1304
Globus Medical Inc 0.1074
Baxter International Inc 1.643
Abbott Laboratories 0.3764

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 2.525B
Total Liabilities (Quarterly) 1.646B
Shareholders Equity (Quarterly) 878.85M
Current Ratio 3.489
Net Debt Paydown Yield -2.27%